| |
|
|
| |
With its family of Accell products, IsoTis has introduced a new class of bone graft substitutes that is much more powerful than the majority of other bone graft substitutes being used in orthopedic surgery today.
IsoTis is presently intensifying its efforts to collect quantitative and clinical data to confirm these very promising preliminary results.
IsoTis tests a sterilized sample of each donor lot using a validated in vitro assay to demonstrate osteoinductivity. Further, each and every product is e-beam sterilized to ensure patient safety. |
|
|
|
